scholarly journals Twenty-year experience with extracorporeal life support as bridge to lung transplantation

2019 ◽  
Vol 157 (6) ◽  
pp. 2515-2525.e10 ◽  
Author(s):  
Alberto Benazzo ◽  
Stefan Schwarz ◽  
Florian Frommlet ◽  
Thomas Schweiger ◽  
Peter Jaksch ◽  
...  
ESC CardioMed ◽  
2018 ◽  
pp. 2520-2524
Author(s):  
Laurent Savale

Despite recent advances in medical management, lung and heart–lung transplantation remains an established treatment option in patients with end-stage pulmonary arterial hypertension (PAH) despite optimal medical therapy. The optimal timing of referral and listing patients for transplantation must take into consideration the co-morbidities, the aetiology of PAH, and the regular risk assessment based on a multidimensional approach. With the exception of PAH due to complex congenital heart disease, double-lung transplantation is the preferred option over combined heart–lung transplantation as cardiac function recovers after transplantation in most cases. The use of extracorporeal life support as a bridge to urgent transplantation may be considered in expert centres in selected patients with refractory right heart failure despite optimal medical management in an intensive care unit. With a survival rate at 5 years varying from 50% to 75%, transplantation in PAH can be considered as a life-saving procedure for patients with severe symptoms.


2014 ◽  
Vol 13 ◽  
pp. S17
Author(s):  
I. Inci ◽  
U. Bürgi ◽  
C. Benden ◽  
L.C. Huber ◽  
P. Kestenholz ◽  
...  

2017 ◽  
Vol 62 (5) ◽  
pp. 588-594 ◽  
Author(s):  
Annemieke Oude Lansink-Hartgring ◽  
Wim van der Bij ◽  
Erik A Verschuuren ◽  
Michiel E Erasmus ◽  
Adrianus J de Vries ◽  
...  

Perfusion ◽  
2017 ◽  
Vol 32 (7) ◽  
pp. 606-608
Author(s):  
Prashant N. Mohite ◽  
Alexander Rosenberg ◽  
Clara Hernández Caballero ◽  
Simona Soresi ◽  
Javid Fatullayev ◽  
...  

Extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplant (LTx) is not uncommon, but it is not commonplace yet. We present a case of a 45-year-old man with cystic fibrosis with recent deterioration in lung function who was initially supported with veno-venous (VV) ECMO. However, he subsequently required conversion to veno-veno-arterial (VVA) ECMO. After 21 days of support, he underwent double lung transplantation, with an uneventful postoperative course. This case shows that, in patients with end-stage respiratory failure awaiting lung transplantation, extracorporeal life support may require escalation to improve gas exchange and address circulatory requirements.


2018 ◽  
Vol 155 (3) ◽  
pp. 1316-1328.e1 ◽  
Author(s):  
Konrad Hoetzenecker ◽  
Laura Donahoe ◽  
Jonathan C. Yeung ◽  
Sassan Azad ◽  
Eddy Fan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document